HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aubrey Capital Management Ltd 11,199$404,0590.23%
HUSSMAN STRATEGIC ADVISORS, INC. 31,500$1,203,3000.23%
SCOUT INVESTMENTS, INC. 265,578$10,009,6340.23%
Virtus Investment Advisers, Inc. 8,579$327,7180.22%
Virtus ETF Advisers LLC 9,231$352,6240.21%
MARSHALL WACE, LLP 2,724,811$104,087,7800.21%
OBERWEIS ASSET MANAGEMENT INC/ 50,500$1,929,1000.20%
Virtus Fund Advisers, LLC 750$28,6500.20%
FOX RUN MANAGEMENT, L.L.C. 17,510$668,8820.20%
DUALITY ADVISERS, LP 40,405$1,543,4710.19%
XTX Topco Ltd 28,504$1,088,8530.19%
SILVERCREST ASSET MANAGEMENT GROUP LLC 633,074$24,183,4270.18%
THRIVENT FINANCIAL FOR LUTHERANS 2,014,233$76,9440.18%
TORRAY INVESTMENT PARTNERS LLC 26,005$993,3910.18%
Bridgefront Capital, LLC 6,238$238,2920.17%
MACQUARIE GROUP LTD 3,444,190$131,568,0000.16%
NJ State Employees Deferred Compensation Plan 27,800$1,061,9600.16%
OAK HILL WEALTH ADVISORS, LLC 12,500$477,5000.16%
Gallacher Capital Management LLC 6,158$235,2360.15%
Mendota Financial Group, LLC 3,318$126,7480.13%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.